A6VND5 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiexa2sfaziw5hxoe7wyjivmi3ywlwvkub5isr7jgabbqncapcjteu/metadata.json
IPFS of structure file: 
bafybeifmqpmby6ky7lqayigxsh52dj2y6ol65hf3pywrk75ibi2tshb6xy/AF-A6VND5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xa3909E2d84022382590ecE114bB40fE85028D066
First NFT owner address (bech32): 
genesis15wgfutvyqg3cykgwecg5hdq0apgz35rxam7q6s
Current NFT ID #166434 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166434
Accession (UniProt):
A6VND5
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Actinobacillus succinogenes (strain ATCC 55618 / DSM 22257 / CCUG 43843 / 130Z)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A6VND5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A6VND5|HEM1_ACTSZ Glutamyl-tRNA reductase OS=Actinobacillus succinogenes (strain ATCC 55618 / DSM 22257 / CCUG 43843 / 130Z) OX=339671 GN=hemA PE=3 SV=1 MTILVLGINHKTATVALREKVAFSEEKRLSALNQIEQLKLAQSTVILSTCNRTEVYLHNKFIQPEQNSAWIDECVAWFAAIHQIQLTDLQDCLYFYQNQQAVTHLMRVACGLDSLILGEPQILGQVKQAYQLAEEYYQRAHGLGKSAVISSELSRLFQKTFSTAKRVRTETNIGESAVSVAYAACSLGRQIFESLQELTILLVGAGETIELAARHLLRHGVKKLMIANRTRARAEALVAKLESPFIEILSLSELQDGLNQADIVISSTGSPTTLISYEMMKQAQIQRRYRPVLIVDIAVPRDVEESIVKLDSVYHYTVDDLQNIINHNLSEREKASEQAEEIIAEECAAFFEWLKVRQASNLIRTYRESADEIRQELLEKAQFSLSQGESADKILDEFSTKLMNKLLHSPTLVMQTMVKQGDSRGLQNFLSVIKK